Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Reexamination Certificate
2005-06-22
2008-12-30
Deak, Leslie R (Department: 3761)
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
C604S006080, C604S004010, C604S005010, C604S006010, C210S645000
Reexamination Certificate
active
07470245
ABSTRACT:
The invention relates to an apparatus system and methods for treatment of virus-infected or pathogen-loaded human blood components separated from normal components comprising a separation apparatus and treatment apparatus system that inactivate pathogens in an extracorporeal blood system.
REFERENCES:
patent: 3705100 (1972-12-01), Blatt et al.
patent: 4191182 (1980-03-01), Popovich et al.
patent: 4663049 (1987-05-01), Kolff et al.
patent: 4735726 (1988-04-01), Duggins
patent: 4737140 (1988-04-01), Lee et al.
patent: 4876241 (1989-10-01), Feldman et al.
patent: 4895558 (1990-01-01), Cham
patent: 5008012 (1991-04-01), Hagihara et al.
patent: 5034135 (1991-07-01), Fischel
patent: 5194145 (1993-03-01), Schoendorfer
patent: 5376263 (1994-12-01), Fischer
patent: 5484396 (1996-01-01), Naficy
patent: 5910252 (1999-06-01), Truitt et al.
patent: 5971948 (1999-10-01), Pages et al.
patent: 6219584 (2001-04-01), Lee
patent: 6258577 (2001-07-01), Goodrich et al.
patent: 6423023 (2002-07-01), Chang et al.
patent: 6433343 (2002-08-01), Cimino et al.
patent: 6548241 (2003-04-01), McBurney et al.
patent: 6835717 (2004-12-01), Hildreth
patent: 2007/0088000 (2007-04-01), Hildreth
Fukumoto T et al. “Viral dynamics of hepatitis C early after orthotopic liver transplantation” abstract Hepatology 1996;24(6):1351.
Garcia-Retortillo M et al. “Hepatitis C virus kinetics during and immediately after liver transplantation” abstract Hepatology 2002;35(3):680.
Firpi RJ et al. “Combination of interferon alfa-2b and ribavirin in liver transplantation recipients with histological recurrent hepatitis C” abstract Liver Transpl. 2002; 8(11):1000.
Samuel D et al. “Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation” abstract Gastroenterology 2003;124(3):642.
Forns X et al. “Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation” abstract J Hepatol 2003;39(3):389.
Chang Yu-An
Lin Hun-Chi
Tu Hosheng
Deak Leslie R
XEPMED, Inc.
LandOfFree
Extracorporeal pathogen reduction system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extracorporeal pathogen reduction system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracorporeal pathogen reduction system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4024880